Back to Search
VINAY PUDUVALLI, M.D.
M.D.
Neurology Physician
NPI: 1437258068IndividualAccepts Medicare
Specialties, Licenses & Credentials
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
35121432(OH)K1902(TX)
CMS Specialties
PrimaryNEUROLOGY
Education
OTHER
Class of 1989
Research & Publications (20)
Phase II trial of irinotecan and thalidomide in adults with recurrent glioblastoma multiforme.
PMID 18314417·Neuro Oncol·2008
3-trial
Induction of apoptosis in primary meningioma cultures by fenretinide.
PMID 15735044·Cancer Res·2005
8-other
TRAIL-induced apoptosis in gliomas is enhanced by Akt-inhibition and is independent of JNK activation.
PMID 15711939·Apoptosis·2005
8-other
Phase II study of fenretinide (NSC 374551) in adults with recurrent malignant gliomas: A North American Brain Tumor Consortium study.
PMID 15514370·J Clin Oncol·2004
3-trial
Inhibition of angiogenesis as a therapeutic strategy against brain tumors.
PMID 15015567·Cancer Treat Res·2004
6-review
Anaplastic oligodendrogliomas: prognostic factors for tumor recurrence and survival.
PMID 14657600·Oncology·2003
4-observational
Brain metastases: biology and the role of the brain microenvironment.
PMID 11595114·Curr Oncol Rep·2001
6-review
Patterns of expression of Rb and p16 in astrocytic gliomas, and correlation with survival.
PMID 11029499·Int J Oncol·2000
8-other
Two phase II trials of temozolomide with interferon-alpha2b (pegylated and non-pegylated) in patients with recurrent glioblastoma multiforme.
PMID 19672263·Br J Cancer·2009
3-trial
Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanoma.
PMID 19267183·J Neurooncol·2009
8-other
Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation.
PMID 19096009·Blood·2009
8-other
Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastoma.
PMID 18581057·J Neurooncol·2008
3-trial
A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies.
PMID 18316473·Neuro Oncol·2008
3-trial
Prognostic factors in multifocal gliomas: in regard to Showalter et al. (Int J Radiat Oncol Biol Phys 2007;69:820-824).
PMID 17967325·Int J Radiat Oncol Biol Phys·2007
8-other
Radio-responsive TRAIL gene therapy for malignant gliomas.
PMID 17704752·Cancer Gene Ther·2007
7-preclinical
A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiforme.
PMID 17031561·J Neurooncol·2007
3-trial
Bortezomib sensitizes human astrocytoma cells to tumor necrosis factor related apoptosis-inducing ligand induced apoptosis.
PMID 17975168·Clin Cancer Res·2007
8-other
Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08.
PMID 16914578·Clin Cancer Res·2006
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1515 HOLCOMBE BLVD, 77030-4009
HOUSTON, TX 77030 - Phone
- (713) 792-6161
Quick Facts
- NPI
- 1437258068
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 37
- Publications
- 20
Are you this provider?
Claim Your Profile